1486 DDR1 expression is associated with a worse prognosis in intrahepatic cholangiocarcinoma

• Xinwei Sher,
• Guy T Clifton,
• Joseph P Eder,
• Amy Mueller,
• Laura A Dillon,
• Thomas Schuerpf,
• Lawrence N Kwong

Affiliations

Xinwei Sher

1Parthenon Therapeutics, Boston, MA, USA

Guy T Clifton

Aff1 grid.416653.30000 0004 4686 9756General SurgerySan Antonio Military Medical Center Fort Sam Houston TX USA

Joseph P Eder

Department of Medicine, Medical Oncology, Yale School of Medicine and Yale Cancer Center, New Haven, Connecticut, USA

Amy Mueller

Jounce Therapeutics, Cambridge, MA, United States

Laura A Dillon

3Parthenon Therapeutics, Boston, MA, USA

Thomas Schuerpf

1Parthenon Therapeutics, Boston, MA, USA

Lawrence N Kwong

2The University of Texas MD Anderson Cancer Center, Houston, TX, USA